Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 May-Jun;77(3):309-22.
doi: 10.1007/BF01908046.

Ultrastructural changes in the human lung following cardiopulmonary bypass

Ultrastructural changes in the human lung following cardiopulmonary bypass

E Anyanwu et al. Basic Res Cardiol. 1982 May-Jun.

Abstract

In order to assess the degree of the pathological changes presenting in the lungs of patients after elective cardiac operations in cardiopulmonary bypass and to determine their prognosis, lung biopsies were taken from the right lower lobe of 36 patients after extracorporeal circulation and studied ultrastructurally. Prepump biopsies from the same presenting anterior portion of the lower lobe of the lung served as controls. Perivascular and interstitial edema featured prominently. Intraalveolar edema and extravasated corpuscular blood elements were observed, too. Damages to the mitochondria and to the lamellar bodies and swelling of the endothelial and alveolar cells were major observations following cardiopulmonary bypass lasting more than 60 minutes. These changes were also prominent in those lungs presenting with severe edema and fibrosis. Many intact type-II pneumocytes presented with enhanced metabolic and secretory activities. Merocrine and apocrine secretions were observed after extracorporeal circulation. The alveoli of the postpump lungs contained numerous detached normal appearing type-II pneumocytes, in contrast to the paucity of such cells in the alveoli of the control biopsies. The prognosis for the patients depends on any one or combination of any of the following factors: the pathological changes present in the lungs prior to the extracorporeal circulation, the duration of the cardiopulmonary bypass, the rate of the elimination of the surfactant and finally the ability of the undamaged type-II pneumocytes to step up the synthesis and secretion of the surface acting agent.

PubMed Disclaimer

Similar articles

References

    1. Bull Soc Int Chir. 1962 Sep-Oct;21:542-51 - PubMed
    1. Am J Clin Pathol. 1960 Nov;34:442-5 - PubMed
    1. J Thorac Cardiovasc Surg. 1973 Mar;65(3):425-32 - PubMed
    1. Am J Pathol. 1970 Feb;58(2):353-73 - PubMed
    1. J Thorac Cardiovasc Surg. 1966 Jun;51(6):767-76 - PubMed